Just days before its initial deadline, U.S. regulators say they need more time to decide whether or not to approve Moderna's respiratory syncytial virus (RSV) vaccine. Just days before its ...
The FDA is working to conclude its review by the end of May 2024. The Food and Drug Administration (FDA) has informed Moderna that its review of the Biologics License Application (BLA) for ...
The Food and Drug Administration on Wednesday approved the world's first RSVvaccine: a shot for adults ages 60 and up, made by pharmaceutical giant GSK. The milestone was decades in the making.
Some results have been hidden because they may be inaccessible to you